← Leaderboards
Yoo-Joung Ko
Beth Israel Deaconess Medical Center
$556,028
Attributed
$556,028
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$556,028 · 1
By mechanism
K23$556,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Lewis C Cantley$35,988,650
- Alex Toker$16,651,718
- Jin-Rong Zhou$4,785,870
- Susumu Kobayashi$5,296,351
- Raghu Kalluri$29,360,132
Others in their field
Top investigators on “Scid Mouse”
- Ann M Arvin · Stanford University$12,530,940
- Jordan S Pober · Yale University$11,234,880
- Jacques Eduardo Nor · University Of Michigan At Ann Arbor$10,041,288
- Madhavan P Nair · State University Of New York At Buffalo$9,783,132
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$9,406,374
- Jerome A. Zack · University Of California Los Angeles$8,722,372
Research focus
Scid MouseCis Platinum CompoundClinical ResearchClinical Trial Phase IProtein Tyrosine KinaseAntineoplasticsCombination ChemotherapyEpidermal Growth FactorGrowth Factor ReceptorsHuman SubjectHuman Therapy EvaluationInhibitor /AntagonistMaleNeoplasm /Cancer ChemotherapyNonhuman Therapy EvaluationPhosphatidylinositol 3 KinasePlatelet Derived Growth FactorProstate NeoplasmsClinical Trial Phase IiPatient Oriented Research
Grant awards (5)
COMBINATION GROWTH FACTOR ANTAGONIST/CHEMOTHERAPY IN PCA$126,462
K23 · FY2004 · CA
COMBINATION GROWTH FACTOR ANTAGONIST/CHEMOTHERAPY IN PCA$125,652
K23 · FY2003 · CA
COMBINATION GROWTH FACTOR ANTAGONIST/CHEMOTHERAPY IN PCA$61,469
K23 · FY2002 · CA
COMBINATION GROWTH FACTOR ANTAGONIST/CHEMOTHERAPY IN PCA$120,796
K23 · FY2001 · CA
COMBINATION GROWTH FACTOR ANTAGONIST/CHEMOTHERAPY IN PCA$121,649
K23 · FY2000 · CA